---
created: 2025-04-13
updated: 2025-04-13T10:52
id: hU1C@5;TUF
specialty: pharmaco
specialty_id: 286
tags:
  - source/ak-original-decks::step-1::zanki-pharmacology
  - source/ak-step1-v11::!flag-these-cards::temporary
  - "source/ak-step1-v11:": 
  - theme/b&b::01-basic-pharm::01-general::05-pharmacokinetics
  - "source/ak-step1-v11:": 
  - theme/firstaid::05-pharmacology::01-pharmacokinetics-pharmacodynamics::03-dosage-calculations
  - "source/ak-step1-v11:": 
  - source/ome-banner
  - "source/ak-step1-v11:": 
  - theme/sketchypharm::!general-pharmacology
  - source/ak-step1-v11::^other::^highyield::4-loweryield"
type: flashcard
---

# Question
How should maintenance dose (= CSS × CL × dosing interval) be adjusted in patients with renal or liver disease?   **Decreased**

---

# Answer
Clearance (CL) determines the dose rate required to maintain a given steady-state plasma concentration (Css)